Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard

被引:25
|
作者
Croome, Kristopher P. [1 ]
Lee, David D. [1 ]
Burns, Justin M. [1 ]
Keaveny, Andrew P. [1 ]
Taner, C. Burcin [1 ]
机构
[1] Mayo Clin Florida, Dept Transplant, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
关键词
D O I
10.1002/lt.25021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Variation in average Model for End-Stage Liver Disease (MELD) score at liver transplantation (LT) by United Network for Organ Sharing (UNOS) regions is well documented. The present study aimed to investigate MELD variation at the interregional, intraregional, and intra-donation service area (DSA) levels. Patients undergoing LT between 2015 and 2016 were obtained from the UNOS standard analysis and research file. The distribution of allocation MELD score including median, skew, and kurtosis was examined for all transplant programs. Intraregional median allocation MELD varied significantly within all 11 UNOS regions. The largest variation between programs was seen in region 5 (MELD 24.0 versus 38.5) and region 3 (MELD 20.5 versus 32.0). Regions 1, 5, and 9 had the largest proportion of programs with a highly negative skewed MELD score (50%, 57%, and 57%, respectively), whereas regions 3, 6, 10, and 11 did not have any programs with a highly negative skew. MELD score distribution was also examined in programs located in the same DSA, where no barriers exist and theoretically no significant difference in allocation should be observed. The largest DSA variation in median allocation MELD score was seen in NYRT-OP1 LiveOnNY (MELD score variation 11), AZOB-OP1 Donor Network of Arizona (MELD score variation 11), MAOB-OP1 New England Organ Bank (MELD score variation 9), and TXGC-OP1 LifeGift Organ Donation Ctr (MELD score variation 9). In conclusion, the present study demonstrates that this MELD disparity is not only present at the interregional level but can be seen within regions and even within DSAs between programs located as close as several city blocks away. Although organ availability likely accounts for a component of this disparity, the present study suggests that transplant center behavior may also play a significant role. Liver Transplantation 24 488-496 2018 AASLD.
引用
收藏
页码:488 / 496
页数:9
相关论文
共 50 条
  • [31] Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers
    Vitale, A.
    D'Amico, F.
    Brolese, A.
    Zanus, G.
    Boccagni, P.
    Neri, D.
    Gringeri, E.
    Valmasoni, M.
    Ciarleglio, F. A.
    Carraro, A.
    Pauletto, A.
    Bonsignore, P.
    Bassi, D.
    Polacco, M.
    D'Amico, D. F.
    Cillo, U.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (06) : 1907 - 1909
  • [32] Model of End-Stage Liver Disease Score and Derived Variants Lack Prognostic Ability After Liver Transplantation
    Kaltenborn, Alexander
    Salinas, Ricardo
    Jaeger, Mark D.
    Lehner, Frank
    Sakirow, Larissa
    Klempnauer, Juergen
    Schrem, Harald
    ANNALS OF TRANSPLANTATION, 2015, 20 : 441 - 448
  • [33] A High Model for End-stage Liver Disease Score Should Not Be Considered a Contraindication to Living Donor Liver Transplantation
    Poon, K-S.
    Chen, T-H.
    Jeng, L-B.
    Yang, H-R.
    Li, P-C.
    Lee, C-C.
    Yeh, C-C.
    Lai, H-C.
    Su, W-P.
    Peng, C. Y.
    Chen, Y-F.
    Ho, Y-J.
    Tsai, P-P.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (02) : 316 - 319
  • [34] Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience
    Rosenthal, Benjamin E.
    Abt, Peter L.
    Schaubel, Douglas E.
    Reddy, K. Rajender
    Bittermann, Therese
    TRANSPLANTATION, 2024, 108 (03) : 713 - 723
  • [35] Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation
    Ichida, Takafumi
    Narita, Yutaka
    Murakami, Romi
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (10) : 1023 - 1024
  • [36] Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients
    Sotiropoulos, Georgios C.
    Vernadakis, Spyridon
    Paul, Andreas
    Hoyer, Dieter P.
    Saner, Fuat H.
    Gallinat, Anja
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (11) : 3346 - 3353
  • [37] Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients
    Georgios C. Sotiropoulos
    Spyridon Vernadakis
    Andreas Paul
    Dieter P. Hoyer
    Fuat H. Saner
    Anja Gallinat
    Digestive Diseases and Sciences, 2016, 61 : 3346 - 3353
  • [38] Survival on Waiting List for Liver Transplantation Before and After Introduction of the Model for End-stage Liver Disease Score
    Tenorio, A. L.
    Macedo, F. I. B.
    Miranda, L. E. C.
    Fernandes, J. L.
    da Silva, C. M.
    Neto, O. L. F.
    Lacerda, C. M.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 407 - 411
  • [39] Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease
    Yan-Hua Lai
    Wei-Dong Duan
    Qiang Yu
    Sheng Ye
    Nian-Jun Xiao
    Dong-Xin Zhang
    Zhi-Qiang Huang
    Zhan-Yu Yang
    Jia-Hong Dong
    World Journal of Gastroenterology, 2015, (20) : 6296 - 6303
  • [40] Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era
    Levi, David M.
    Tzakis, Andreas G.
    Martin, Paul
    Nishida, Seigo
    Island, Eddie
    Moon, Jang
    Selvaggi, Gennaro
    Tekin, Akin
    Madrazo, Beatrice L.
    Narayanan, Govindarajan
    Garcia, Monica T.
    Feun, Lynn G.
    Tryphonopoulos, Panagiotis
    Skartsis, Nikolaos
    Livingstone, Alan S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 727 - 734